158 related articles for article (PubMed ID: 9106629)
21. Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims.
Sastre M; García-Sevilla JA
Neurochem Int; 1997 Jan; 30(1):63-72. PubMed ID: 9116589
[TBL] [Abstract][Full Text] [Related]
22. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
Wiest SA; Steinberg MI
Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
[TBL] [Abstract][Full Text] [Related]
23. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
King PR; Gundlach AL; Louis WJ
Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
[TBL] [Abstract][Full Text] [Related]
24. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
Su RB; Li J; Li X; Qin BY
Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species production by monoamine oxidases in intact cells.
Pizzinat N; Copin N; Vindis C; Parini A; Cambon C
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):428-31. PubMed ID: 10498294
[TBL] [Abstract][Full Text] [Related]
28. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
Escribá PV; Ozaita A; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
[TBL] [Abstract][Full Text] [Related]
31. Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A.
Pizzinat N; Girolami JP; Parini A; Pecher C; Ordener C
Kidney Int; 1999 Oct; 56(4):1391-9. PubMed ID: 10504491
[TBL] [Abstract][Full Text] [Related]
32. [3H]idazoxan binds to mitochondrial I2 imidazoline binding sites in isolated cells from rabbit kidney proximal tubule.
Gargalidis-Moudanos C; Parini A
Ann N Y Acad Sci; 1995 Jul; 763():172-3. PubMed ID: 7677328
[No Abstract] [Full Text] [Related]
33. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
[TBL] [Abstract][Full Text] [Related]
34. Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway.
Macinnes N; Duty S
Br J Pharmacol; 2004 Dec; 143(8):952-9. PubMed ID: 15545290
[TBL] [Abstract][Full Text] [Related]
35. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC
Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915
[No Abstract] [Full Text] [Related]
36. Relationship between imidazoline(2) sites and monoamine oxidase.
Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
[TBL] [Abstract][Full Text] [Related]
37. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
Holt A; Todd KG; Baker GB
Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
[TBL] [Abstract][Full Text] [Related]
38. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
[TBL] [Abstract][Full Text] [Related]
39. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.
Wiest SA; Steinberg MI
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):209-16. PubMed ID: 10494892
[TBL] [Abstract][Full Text] [Related]
40. Localization of the imidazoline binding domain on monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
Mol Pharmacol; 1997 Oct; 52(4):549-53. PubMed ID: 9380016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
